A Pilot study on fluid therapy during surgery in children and its effect on blood sugar and ketones.
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2018/08/015337
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All infants and children up to 6 years of age, posted for elective major surgeries in TATA memorial hospital [TMH] and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC).
Exclusion Criteria
.Infants and Children with underlying endocrine or metabolic disorders.
2.Infants and children who are on steroid therapy.
3.Neonates
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To observe the current practices of perioperative fluid therapy at a tertiary care center, <br/ ><br>(TMH and ACTREC) and to assess its adequacy in maintaining plasma glucose and lipid homeostasis without mobilization of the bodyâ??s carbohydrate and lipid reserves.Timepoint: 1. Immediately after induction of anaesthesia <br/ ><br>2. Just before extubation <br/ ><br>3. 2 hours after surgery
- Secondary Outcome Measures
Name Time Method 1.To assess the relationship between the preoperative blood glucose concentrations in the patients and their duration of starvation. <br/ ><br>2. To see if there is any correlation between arterial and capillary blood sugar and blood ketone levelsTimepoint: 1. Immediately after induction of anaesthesia <br/ ><br>2. Just before extubation <br/ ><br>3. 2 hours after surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link perioperative fluid therapy to glucose dysregulation in pediatric oncology patients?
How does isotonic vs. hypotonic fluid administration during pediatric cancer surgery impact postoperative ketosis and hyperglycemia?
Which metabolic biomarkers in CTRI/2018/08/015337 correlate with glucose homeostasis outcomes in pediatric oncology fluid therapy?
What adverse metabolic events are associated with perioperative fluid therapy in C00-D49 pediatric patients and how are they mitigated?
How does perioperative fluid management in pediatric oncology compare to insulin-based glucose control strategies post-surgery?